147 related articles for article (PubMed ID: 32043302)
1. Omiganan Enhances Imiquimod-Induced Inflammatory Responses in Skin of Healthy Volunteers.
Niemeyer-van der Kolk T; Assil S; Buters TP; Rijsbergen M; Klaassen ES; Feiss G; Florencia E; Prens EP; Burggraaf J; van Doorn MBA; Rissmann R; Moerland M
Clin Transl Sci; 2020 May; 13(3):573-579. PubMed ID: 32043302
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive, Multimodal Characterization of an Imiquimod-Induced Human Skin Inflammation Model for Drug Development.
van der Kolk T; Assil S; Rijneveld R; Klaassen ES; Feiss G; Florencia E; Prens EP; Burggraaf J; Moerland M; Rissmann R; van Doorn MBA
Clin Transl Sci; 2018 Nov; 11(6):607-615. PubMed ID: 29768709
[TBL] [Abstract][Full Text] [Related]
3. Oral prednisolone suppresses skin inflammation in a healthy volunteer imiquimod challenge model.
Assil S; Buters TP; Hameeteman PW; Hallard C; Treijtel N; Niemeyer-Van der Kolk T; de Kam ML; Florencia EFIII; Prens EP; van Doorn MBA; Rissmann R; Klarenbeek NB; Jansen MAA; Moerland M
Front Immunol; 2023; 14():1197650. PubMed ID: 37545524
[TBL] [Abstract][Full Text] [Related]
4. Self-administered topical imiquimod treatment of vulvar intraepithelial neoplasia. A report of four cases.
Davis G; Wentworth J; Richard J
J Reprod Med; 2000 Aug; 45(8):619-23. PubMed ID: 10986679
[TBL] [Abstract][Full Text] [Related]
5. Detection of human papillomavirus (HPV) 16-specific CD4+ T-cell immunity in patients with persistent HPV16-induced vulvar intraepithelial neoplasia in relation to clinical impact of imiquimod treatment.
van Poelgeest MI; van Seters M; van Beurden M; Kwappenberg KM; Heijmans-Antonissen C; Drijfhout JW; Melief CJ; Kenter GG; Helmerhorst TJ; Offringa R; van der Burg SH
Clin Cancer Res; 2005 Jul; 11(14):5273-80. PubMed ID: 16033846
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic effect of Imiquimod enhanced ALA-PDT on cutaneous squamous cell carcinoma.
Bhatta AK; Wang P; Keyal U; Zhao Z; Ji J; Zhu L; Wang X; Zhang G
Photodiagnosis Photodyn Ther; 2018 Sep; 23():273-280. PubMed ID: 30030167
[TBL] [Abstract][Full Text] [Related]
7. Imiquimod-induced clearance of HPV is associated with normalization of immune cell counts in usual type vulvar intraepithelial neoplasia.
Terlou A; van Seters M; Kleinjan A; Heijmans-Antonissen C; Santegoets LA; Beckmann I; van Beurden M; Helmerhorst TJ; Blok LJ
Int J Cancer; 2010 Dec; 127(12):2831-40. PubMed ID: 21351262
[TBL] [Abstract][Full Text] [Related]
8. Successful management of viral infections and other dermatoses with imiquimod 5% cream.
Berman B; Hengge U; Barton S
Acta Derm Venereol Suppl (Stockh); 2003 Sep; (214):12-7. PubMed ID: 14606277
[No Abstract] [Full Text] [Related]
9. Mechanism of pathogenesis of imiquimod-induced skin inflammation in the mouse: a role for interferon-alpha in dendritic cell activation by imiquimod.
Ueyama A; Yamamoto M; Tsujii K; Furue Y; Imura C; Shichijo M; Yasui K
J Dermatol; 2014 Feb; 41(2):135-43. PubMed ID: 24387343
[TBL] [Abstract][Full Text] [Related]
10. Calcipotriol and betamethasone dipropionate exhibit different immunomodulatory effects on imiquimod-induced murine psoriasiform dermatitis.
Takeoka S; Shimizu T; Kamata M; Hau CS; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
J Dermatol; 2020 Feb; 47(2):155-162. PubMed ID: 31762070
[TBL] [Abstract][Full Text] [Related]
11. Does imiquimod pretreatment optimize 308-nm excimer laser (UVB) therapy in psoriasis patients?
Tacastacas JD; Oyetakin-White P; Soler DC; Young A; Groft S; Honda K; Cooper KD; McCormick TS
Photodermatol Photoimmunol Photomed; 2017 Jul; 33(4):193-202. PubMed ID: 28168735
[TBL] [Abstract][Full Text] [Related]
12. Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response.
van Poelgeest MI; Welters MJ; Vermeij R; Stynenbosch LF; Loof NM; Berends-van der Meer DM; Löwik MJ; Hamming IL; van Esch EM; Hellebrekers BW; van Beurden M; Schreuder HW; Kagie MJ; Trimbos JB; Fathers LM; Daemen T; Hollema H; Valentijn AR; Oostendorp J; Oude Elberink JH; Fleuren GJ; Bosse T; Kenter GG; Stijnen T; Nijman HW; Melief CJ; van der Burg SH
Clin Cancer Res; 2016 May; 22(10):2342-50. PubMed ID: 26813357
[TBL] [Abstract][Full Text] [Related]
13. Enhanced type I interferon signaling and recruitment of chemokine receptor CXCR3-expressing lymphocytes into the skin following treatment with the TLR7-agonist imiquimod.
Wenzel J; Uerlich M; Haller O; Bieber T; Tueting T
J Cutan Pathol; 2005 Apr; 32(4):257-62. PubMed ID: 15769273
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of the innate and cellular immune response in patients with genital warts treated with topical imiquimod cream 5%.
Arany I; Tyring SK; Stanley MA; Tomai MA; Miller RL; Smith MH; McDermott DJ; Slade HB
Antiviral Res; 1999 Aug; 43(1):55-63. PubMed ID: 10480263
[TBL] [Abstract][Full Text] [Related]
15. A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod.
Tyring SK; Arany I; Stanley MA; Tomai MA; Miller RL; Smith MH; McDermott DJ; Slade HB
J Infect Dis; 1998 Aug; 178(2):551-5. PubMed ID: 9697742
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of high-grade vulval intra-epithelial neoplasia with imiquimod 5% in a renal transplant recipient.
Khatun A; Lotery H; Sundaram S
Int J STD AIDS; 2019 Feb; 30(2):198-200. PubMed ID: 30284955
[TBL] [Abstract][Full Text] [Related]
17. A pre-existing coordinated inflammatory microenvironment is associated with complete response of vulvar high-grade squamous intraepithelial lesions to different forms of immunotherapy.
Abdulrahman Z; de Miranda NFCC; Hellebrekers BWJ; de Vos van Steenwijk PJ; van Esch EMG; van der Burg SH; van Poelgeest MIE
Int J Cancer; 2020 Nov; 147(10):2914-2923. PubMed ID: 32574376
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of vulvar intraepithelial neoplasia with topical imiquimod 5% cream in a lung transplanted patient.
Travis LB; Weinberg JM; Krumholz BA
Acta Derm Venereol; 2002; 82(6):475-6. PubMed ID: 12575863
[No Abstract] [Full Text] [Related]
19. IRF-2 haploinsufficiency causes enhanced imiquimod-induced psoriasis-like skin inflammation.
Kawaguchi M; Oka T; Sugaya M; Suga H; Kimura T; Morimura S; Fujita H; Sato S
J Dermatol Sci; 2018 Apr; 90(1):35-45. PubMed ID: 29305258
[TBL] [Abstract][Full Text] [Related]
20. Azithromycin impairs TLR7 signaling in dendritic cells and improves the severity of imiquimod-induced psoriasis-like skin inflammation in mice.
Huang SW; Chen YJ; Wang ST; Ho LW; Kao JK; Narita M; Takahashi M; Wu CY; Cheng HY; Shieh JJ
J Dermatol Sci; 2016 Oct; 84(1):59-70. PubMed ID: 27449383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
